Nuwellis Inc (NUWE NASDAQ) stock market data APIs
$1.2603
0.03(2.4%)
as of August 17, 2026
Try our APIs with
free plan!
Nuwellis Inc Financial Data Overview
Price chart is built with
Anychart
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Prev. Close
1.2603
Open
1.2898
High
1.2916
Low
1.2164
52 wk Range
1.224-199.5
Market Cap
4 001 K
P/E Ratio
0.0277
Shares Outstanding
3 175 K
Revenue
9 013 K
EPS
-26.64
Beta
0.286
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Nuwellis Inc data using free add-ons & libraries
Get Nuwellis Inc Fundamental Data
Nuwellis Inc Fundamental data includes:
- Net Revenue: 9 013 K
- EBITDA: -12 725 000
- Earnings Per Share: 45
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: -23.8
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nuwellis Inc News
New
Nuwellis GAAP EPS of -$26.24, revenue of $1.97M
* Nuwellis press release [https://seekingalpha.com/pr/20618135-nuwellis-reports-second-quarter-2026-financial-results-and-business-highlights-focused-on] (NUWE [https://seekingalpha.com/symbol/NUWE]...
Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer
MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced...
Top Biotech Gainers: GCTK On The Move, BHC, CORT Boost FY'26 Outlook, NEOG On Watch
(RTTNews) - Today's top gainers included Glucotrack, whose subsidiary announced progress in the development strategy for LT-100, a novel non-narcotic therapy; Nuwellis, following expanded clinical rec...
Top Biotech Gainers: NXTC Soars On Merger Deal, BMGL Moves Past Nasdaq Woes, OTLK Awaits FDA Verdict
(RTTNews) - Today's top gainers in the biotech space include NextCure, ahead of its planned merger with a private company that will create a newly branded public entity; Basel Medical, which recently ...
Get Nuwellis Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
